Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma

Conditions:   Tumor;   Metastatic Melanoma;   Melanoma Interventions:   Drug: OBX-115;   Drug: Acetazolamide;   Drug: Cyclophosphamide;   Drug: Furosemide;   Drug: Mesna;   Drug: Fludarabine Phosphate Sponsor:   M.D. Anderson Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials